Filing Details

Accession Number:
0001562088-24-000183
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-02 16:59:11
Reporting Period:
2024-07-01
Accepted Time:
2024-07-02 16:59:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1562088 Duolingo Inc. DUOL Services-Prepackaged Software (7372) 453055872
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1869669 Matthew Skaruppa C/O Duolingo, Inc.
5900 Penn Avenue
Pittsburgh PA 15206
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-07-01 8,000 $14.42 103,731 No 4 M Direct
Class A Common Stock Disposition 2024-07-01 2,293 $195.57 101,438 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 1,001 $196.56 100,437 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 738 $198.23 99,699 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 1,139 $199.80 98,560 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 1,627 $200.55 96,933 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 602 $201.74 96,331 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 400 $202.57 95,931 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 100 $203.47 95,831 No 4 S Direct
Class A Common Stock Disposition 2024-07-01 100 $205.30 95,731 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2024-07-01 8,000 $0.00 8,000 $14.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,427 2030-03-10 No 4 M Direct
Footnotes
  1. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on June 9, 2023.
  2. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $195.13 to $196.11, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $196.13 to $197.03, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $197.92 to $198.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $199.21 to $200.19 inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $200.21 to $201.11, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $201.30 to $202.04, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $202.41 to $202.84, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  9. The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $203.43 to $203.54, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  10. The shares subject to the option are fully vested and exercisable.